{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T01:23:32Z","timestamp":1770341012740,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T00:00:00Z","timestamp":1451692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Polish Ministry of Science and Higher Education","award":["IP2011018771"],"award-info":[{"award-number":["IP2011018771"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jmii.2015.04.003","type":"journal-article","created":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T22:40:33Z","timestamp":1435185633000},"page":"439-444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Second-line anti-tuberculosis drug resistance and its genetic determinants in\u00a0multidrug-resistant Mycobacterium tuberculosis clinical isolates"],"prefix":"10.1016","volume":"49","author":[{"given":"Zofia","family":"Baku\u0142a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1296-4934","authenticated-orcid":false,"given":"Agnieszka","family":"Napi\u00f3rkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u0142","family":"Kami\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Augustynowicz-Kope\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zofia","family":"Zwolska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Bielecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Jagielski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2015.04.003_bib1","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1128\/JCM.05286-11","article-title":"High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility","volume":"50","author":"Devasia","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2015.04.003_bib2","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1128\/AAC.06272-11","article-title":"Extending the definition of the gyrB Quinolone Resistance-Determining Region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis","volume":"56","author":"Pantel","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.04.003_bib3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.diagmicrobio.2013.06.031","article-title":"Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China","volume":"77","author":"Du","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2015.04.003_bib4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/AAC.49.2.571-577.2005","article-title":"Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis","volume":"49","author":"Maus","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.04.003_bib5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1128\/AAC.01030-10","article-title":"Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis","volume":"55","author":"Brossier","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.04.003_bib6","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1128\/JCM.00572-10","article-title":"Spoligotype-based comparative population structure analysis of multidrug-resistant and isoniazid-monoresistant Mycobacterium tuberculosis complex clinical isolates in Poland","volume":"48","author":"Jagielski","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2015.04.003_bib7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/jcm.31.2.406-409.1993","article-title":"Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology","volume":"31","author":"van Embden","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2015.04.003_bib8","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1128\/AAC.00920-10","article-title":"Molecular characterization of fluoroquinolone resistance in Mycobacterium tuberculosis: functional analysis of gyrA mutation at position 74","volume":"55","author":"Lau","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.04.003_bib9","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1128\/AAC.05101-11","article-title":"Characterization of mutations conferring extensive drug resistance to Mycobacterium tuberculosis isolates in Pakistan","volume":"55","author":"Ali","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.04.003_bib10","series-title":"Global tuberculosis control: surveillance, planning, financing","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.jmii.2015.04.003_bib11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/jac\/dkp452","article-title":"Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal","volume":"65","author":"Perdig\u00e3o","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2015.04.003_bib12","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1128\/AAC.01550-10","article-title":"Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis","volume":"55","author":"Campbell","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.04.003_bib13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/dkr566","article-title":"A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system","volume":"67","author":"Maruri","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2015.04.003_bib14","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jac\/dks033","article-title":"gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis","volume":"67","author":"Sirgel","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2015.04.003_bib15","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1128\/AAC.00541-09","article-title":"Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam","volume":"53","author":"Duong","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.04.003_bib16","doi-asserted-by":"crossref","first-page":"e3327","DOI":"10.1371\/journal.pone.0033275","article-title":"Evaluation of genetic mutations\u00a0associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic\u00a0review","volume":"7","author":"Georghiou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2015.04.003_bib17","doi-asserted-by":"crossref","first-page":"e100078","DOI":"10.1371\/journal.pone.0100078","article-title":"Screening for streptomycin resistance-conferring mutations in Mycobacterium tuberculosis clinical isolates from Poland","volume":"9","author":"Jagielski","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2015.04.003_bib18","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1128\/AAC.00851-09","article-title":"High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene","volume":"53","author":"Jugheli","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.04.003_bib19","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/jac\/dkr109","article-title":"Comparison of clinical isolates and in\u00a0vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis","volume":"66","author":"Engstr\u00f6m","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2015.04.003_bib20","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1128\/JCM.02701-13","article-title":"Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations","volume":"52","author":"Rodwell","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2015.04.003_bib21","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jmb.2004.06.003","article-title":"Crystal structure of the TetR\/CamR family repressor Mycobacterium tuberculosis EthR implicated in ethionamide resistance","volume":"340","author":"Dover","year":"2004","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jmii.2015.04.003_bib22","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1365-2672.2010.04840.x","article-title":"Usefulness of resistant gene markers for predicting treatment outcome on second-line anti-tuberculosis drugs","volume":"109","author":"Leung","year":"2010","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.jmii.2015.04.003_bib23","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1128\/AAC.47.12.3799-3805.2003","article-title":"ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates","volume":"47","author":"Morlock","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.04.003_bib24","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.1073\/pnas.97.17.9677","article-title":"Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis","volume":"97","author":"De Barber","year":"2000","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118215007471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118215007471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:20:53Z","timestamp":1761657653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118215007471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1684118215007471"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2015.04.003","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Second-line anti-tuberculosis drug resistance and its genetic determinants in\u00a0multidrug-resistant Mycobacterium tuberculosis clinical isolates","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2015.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}